In addition, the combination of this deformable nano-vaccine and anti-PD-L1 antibody therapy could significantly inhibit tumor growth in tumor-bearing mice, with about half of the mice exhibiting complete tumor regression in vivo (83) (Figures 4A, B). This evidence concerns the gene CD274 and neoplasm.